PRODIGE: a randomized placebo-controlled trial of dalteparin …

PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. Perry JR, Julian JA, Laperriere NJ, Geerts W, Agnelli G, Rogers LR, Malkin MG, Sawaya R, Baker R, Falanga A, Parpia S, Finch T, Levine MN. J Thromb Haemost. 2010 Sep;8(9):1959-65. (suite…)
Plus